Objective Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$297K Hold
1,120
– – 0.27% 79
2026
Q2
$284K Sell
1,120
-10
-0.9% -$2.33K 0.25% 78
2026
Q1
$276K Buy
+1,130
New +$263K 0.28% 74
2025
Q1
– Sell
-1,800
Closed -$260K – 113
2024
Q4
$260K Sell
1,800
-362
-17% -$56.1K 0.17% 115
2024
Q3
$350K Buy
+2,162
New +$344K 0.21% 104
2024
Q1
$374K Sell
2,362
-108
-4% -$17.2K 0.25% 86
2023
Q4
$387K Sell
2,470
-201
-8% -$30.8K 0.3% 72
2023
Q3
$416K Sell
2,671
-794
-23% -$131K 0.37% 60
2023
Q2
$574K Buy
3,465
+3
+0.1% +$484 0.5% 46
2023
Q1
$537K Sell
3,462
-29
-0.8% -$4.68K 0.49% 48
2022
Q4
$617K Buy
3,491
+125
+4% +$21.6K 0.61% 44
2022
Q3
$550K Buy
3,366
+33
+1% +$5.58K 0.59% 42
2022
Q2
$592K Buy
3,333
+433
+15% +$77.1K 0.6% 44
2022
Q1
$514K Sell
2,900
-100
-3% -$17K 0.4% 59
2021
Q4
$513K Buy
+3,000
New +$491K 0.36% 59

Other funds holding JNJ

Objective Capital Management's JNJ Position: Q3 2026 in Review

Objective Capital Management held its Johnson & Johnson (JNJ) position steady in Q3 2026 at 1,120 shares worth $297K. The position accounts for 0.27% of the portfolio, ranked #79.

Objective Capital Management first reported a position in JNJ in Q4 2021 and has held it in 15 quarters since. The position peaked at $617K in Q4 2022. 1,349 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Objective Capital Management held 1,120 shares of Johnson & Johnson worth $297K as of Q3 2026.
  • Objective Capital Management left its Johnson & Johnson share count unchanged in Q3 2026.
  • Johnson & Johnson made up 0.27% of Objective Capital Management's portfolio in Q3 2026, its #79 holding.
  • Objective Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 15 quarters since.
  • Objective Capital Management's Johnson & Johnson position peaked at $617K in Q4 2022.
  • 1,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Objective Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.